Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study. (Record no. 25083111)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02338 a2200685 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517042659.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201510s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1097-6787 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.jaad.2015.03.040 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Dogra, Sunil |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20151006 |
| 245 00 - TITLE STATEMENT | |
| Title | Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of the American Academy of Dermatology |
| Date of publication, distribution, etc. | Aug 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 331-3.e1 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Comparative Study; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Maximum Tolerated Dose |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Psoriasis |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quality of Life |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk Assessment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Time |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Withholding Treatment |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | D S, Krupashankar |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Budamakuntla, Leelavathy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Srinivas, C R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Khopkar, Uday |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gupta, Sandesh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shetty, Narendra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pratap, Dasiga Venkata Subrahmanya |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gopal, M G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rao, T Narayana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Garg, Vijay |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sumathy, T K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Saraswat, Abir |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bhat, Ramesh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kura, Mahendra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pandey, Neeraj |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shah, Radha |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sai Krishna, Kotla |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Padmaja, Dalavai |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Manmohan, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | M S, Ramakrishnan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barve, Abhijit |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Montero, Enrique |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of the American Academy of Dermatology |
| Related parts | vol. 73 |
| -- | no. 2 |
| -- | p. 331-3.e1 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jaad.2015.03.040">https://doi.org/10.1016/j.jaad.2015.03.040</a> |
| Public note | Available from publisher's website |
No items available.